Researchers developed an innovative approach -- demonstrated in mouse models and isolated human brain tissue -- to safely and effectively deliver therapeutics into the brain, providing new possibilities for treating a wide range of neurological and psychiatric diseases. The study introduces a first-of-its-kind blood-brain barrier-crossing conjugate (BCC) system, designed to overcome the protective barrier that typically blocks large biomolecules from reaching the central nervous system (CNS).
source https://www.sciencedaily.com/releases/2024/11/241125125221.htm
Cybercrime 'crew' stole $635,000 in Taylor Swift concert tickets
-
New York prosecutors say that two people working at a third-party
contractor for the StubHub online ticket marketplace made $635,000 after
almost 1,000 con...
3 hours ago
Welcome to the 'The Fact Factory' friends. Its an interesting Hot Spot which brings to you amazing and little known facts from all over the world. So, sit back, take a tour around the world and enjoy the trivia.
No comments:
Post a Comment